JP2009543567A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009543567A5 JP2009543567A5 JP2009519869A JP2009519869A JP2009543567A5 JP 2009543567 A5 JP2009543567 A5 JP 2009543567A5 JP 2009519869 A JP2009519869 A JP 2009519869A JP 2009519869 A JP2009519869 A JP 2009519869A JP 2009543567 A5 JP2009543567 A5 JP 2009543567A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- acid molecule
- stretch
- nucleotides
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06014957 | 2006-07-18 | ||
| EP06014957.2 | 2006-07-18 | ||
| PCT/EP2007/006387 WO2008009437A2 (en) | 2006-07-18 | 2007-07-18 | Sdf-i binding nucleic acids |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009543567A JP2009543567A (ja) | 2009-12-10 |
| JP2009543567A5 true JP2009543567A5 (enExample) | 2010-09-02 |
| JP5380287B2 JP5380287B2 (ja) | 2014-01-08 |
Family
ID=38947372
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009519869A Expired - Fee Related JP5380287B2 (ja) | 2006-07-18 | 2007-07-18 | Ｓｄｆ−１結合核酸 |
Country Status (16)
| Country | Link |
|---|---|
| US (5) | US8314223B2 (enExample) |
| EP (1) | EP2041282B1 (enExample) |
| JP (1) | JP5380287B2 (enExample) |
| KR (2) | KR101561652B1 (enExample) |
| CN (2) | CN101506364B (enExample) |
| AR (1) | AR061929A1 (enExample) |
| AU (1) | AU2007276435C1 (enExample) |
| BR (1) | BRPI0714844B8 (enExample) |
| CA (1) | CA2658267C (enExample) |
| DK (1) | DK2041282T3 (enExample) |
| ES (1) | ES2663404T3 (enExample) |
| MX (1) | MX2009000656A (enExample) |
| PL (1) | PL2041282T3 (enExample) |
| PT (1) | PT2041282T (enExample) |
| RU (1) | RU2590709C2 (enExample) |
| WO (1) | WO2008009437A2 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5380287B2 (ja) | 2006-07-18 | 2014-01-08 | ノクソン・ファルマ・アクチエンゲゼルシャフト | Ｓｄｆ−１結合核酸 |
| PT2190991T (pt) * | 2007-08-06 | 2019-12-16 | Noxxon Pharma Ag | Ácidos nucleicos que se ligam a sdf 1 e a sua utilização |
| JP5463621B2 (ja) * | 2008-02-27 | 2014-04-09 | ソニー株式会社 | 標的物質の定量方法 |
| WO2009149921A2 (en) * | 2008-06-11 | 2009-12-17 | Bionucleon S.R.L. | Inhibition of hrp-3 using modified oligonucleotides |
| TWI578992B (zh) * | 2009-04-30 | 2017-04-21 | 諾克森製藥股份有限公司 | 與鐵調節激素（ｈｅｐｃｉｄｉｎ）結合之核酸類 |
| WO2012025251A1 (en) * | 2010-08-27 | 2012-03-01 | Noxxon Pharma Ag | Nucleic acids for treatment of chronic complications of diabetes |
| SG188220A1 (en) * | 2010-09-09 | 2013-04-30 | Noxxon Pharma Ag | Sdf-1 binding nucleic acids and the use thereof in cancer treatment |
| WO2012055573A1 (en) * | 2010-10-29 | 2012-05-03 | Noxxon Pharma Ag | Use of hepcidin binding nucleic acids for depletion of hepcidin from the body |
| DK2872147T3 (da) | 2012-07-13 | 2023-02-20 | Wave Life Sciences Ltd | Fremgangsmåde til fremstilling af kirale oligonukleotider |
| EP3233112A2 (en) * | 2014-12-17 | 2017-10-25 | Cancer Research Technology Limited | Anti-cxcl12 antibody molecules and their uses |
| WO2017178119A1 (en) * | 2016-04-15 | 2017-10-19 | Noxxon Pharma Ag | Method of modulating the number and the distribution of tumor-infiltrating leukocytes in tumors |
| US11221270B2 (en) * | 2018-02-27 | 2022-01-11 | Kevan M Evans | Method and apparatus for detecting slow leaks |
| WO2021178923A1 (en) | 2020-03-06 | 2021-09-10 | Drinksavvy, Inc. | Devices and methods for detecting a target analyte of interest |
| EP4173639A4 (en) | 2020-06-26 | 2024-03-13 | RaQualia Pharma Inc. | METHOD FOR SELECTING A CANCER PATIENT FOR WHICH COMBINATION THERAPY OF A RETINOID AND A CANCER TREATMENT AGENT WILL BE EFFECTIVE, AND COMBINATION DRUG OF A RETINOID AND A CANCER TREATMENT AGENT |
| WO2023154452A1 (en) | 2022-02-11 | 2023-08-17 | Waypoint Bio, Inc. | Cellular staining probes for analyte detection |
| TW202430127A (zh) * | 2023-01-19 | 2024-08-01 | 國立陽明交通大學 | 可用於遞送內質網壓力誘導劑或免疫療法的複合奈米粒及其用途 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5567588A (en) | 1990-06-11 | 1996-10-22 | University Research Corporation | Systematic evolution of ligands by exponential enrichment: Solution SELEX |
| US6011020A (en) | 1990-06-11 | 2000-01-04 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligand complexes |
| IE920562A1 (en) * | 1991-02-21 | 1992-08-26 | Gilead Sciences | Aptamer specific for biomolecules and method of making |
| US5840867A (en) | 1991-02-21 | 1998-11-24 | Gilead Sciences, Inc. | Aptamer analogs specific for biomolecules |
| US5582981A (en) | 1991-08-14 | 1996-12-10 | Gilead Sciences, Inc. | Method for identifying an oligonucleotide aptamer specific for a target |
| DE69932510T2 (de) * | 1998-03-24 | 2007-02-15 | Chugai Seiyaku K.K. | Vaskularisierungsinhibitoren |
| US6670149B1 (en) * | 1999-03-01 | 2003-12-30 | Millennium Pharmaceuticals, Inc. | TWIK-5 potassium channel nucleic acids and uses therefor |
| US6949243B1 (en) | 1999-11-24 | 2005-09-27 | Schering Corporation | Methods of inhibiting metastasis |
| EP1133988A1 (en) * | 2000-03-11 | 2001-09-19 | Biognostik Gesellschaft für biomolekulare Diagnostik mbH | Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene |
| ATE347695T1 (de) * | 2001-06-07 | 2006-12-15 | Chemocentryx Inc | Zellwanderungsassay |
| US7468253B2 (en) | 2001-06-07 | 2008-12-23 | Chemocentryx, Inc. | Method for multiple chemokine receptor screening for antagonists using RAM assay |
| GB0225833D0 (en) | 2002-11-06 | 2002-12-11 | Univ Leeds | Nucleic acid ligands and uses therefor |
| WO2006032143A1 (en) | 2004-09-23 | 2006-03-30 | Arc Pharmaceuticals, Inc. | Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions or inflammatory disease using low sulphate fucans |
| WO2006058705A1 (de) * | 2004-11-29 | 2006-06-08 | Noxxon Pharma Ag | Vasopressin bindende l-nukleinsäure |
| ES2385924T3 (es) | 2006-02-02 | 2012-08-03 | Allergan, Inc. | Inhibidores de la actividad de CXCR4 para su uso en el tratamiento de trastornos oculares |
| JP5380287B2 (ja) | 2006-07-18 | 2014-01-08 | ノクソン・ファルマ・アクチエンゲゼルシャフト | Ｓｄｆ−１結合核酸 |
| SI2066351T1 (sl) | 2006-10-02 | 2016-02-29 | E.R. Squibb & Sons, L.L.C. | Humana protitelesa, ki vežejo cxcr4 in njihova uporaba |
| EP2100140B1 (en) | 2006-11-30 | 2015-05-06 | University Of Virginia Patent Foundation | Methods for diagnosing fibrotic lung diseases |
| PT2190991T (pt) | 2007-08-06 | 2019-12-16 | Noxxon Pharma Ag | Ácidos nucleicos que se ligam a sdf 1 e a sua utilização |
| US20090274687A1 (en) | 2008-05-02 | 2009-11-05 | University Of Miami | Attenuation of hypoxia induced cardiovascular disorders |
-
2007
- 2007-07-18 JP JP2009519869A patent/JP5380287B2/ja not_active Expired - Fee Related
- 2007-07-18 AR ARP070103212A patent/AR061929A1/es active IP Right Grant
- 2007-07-18 MX MX2009000656A patent/MX2009000656A/es active IP Right Grant
- 2007-07-18 WO PCT/EP2007/006387 patent/WO2008009437A2/en not_active Ceased
- 2007-07-18 KR KR1020137020754A patent/KR101561652B1/ko not_active Expired - Fee Related
- 2007-07-18 PT PT77861607T patent/PT2041282T/pt unknown
- 2007-07-18 BR BRPI0714844A patent/BRPI0714844B8/pt active IP Right Grant
- 2007-07-18 KR KR1020097000923A patent/KR101466931B1/ko active Active
- 2007-07-18 PL PL07786160T patent/PL2041282T3/pl unknown
- 2007-07-18 CN CN2007800305243A patent/CN101506364B/zh active Active
- 2007-07-18 EP EP07786160.7A patent/EP2041282B1/en active Active
- 2007-07-18 DK DK07786160.7T patent/DK2041282T3/en active
- 2007-07-18 AU AU2007276435A patent/AU2007276435C1/en active Active
- 2007-07-18 RU RU2009105494/10A patent/RU2590709C2/ru active
- 2007-07-18 CA CA2658267A patent/CA2658267C/en active Active
- 2007-07-18 CN CN201310486348.1A patent/CN103555725B/zh active Active
- 2007-07-18 ES ES07786160.7T patent/ES2663404T3/es active Active
-
2009
- 2009-01-18 US US12/374,311 patent/US8314223B2/en active Active
-
2012
- 2012-10-13 US US13/651,385 patent/US9035038B2/en active Active
-
2015
- 2015-05-06 US US14/705,809 patent/US9822369B2/en active Active
-
2017
- 2017-11-20 US US15/818,618 patent/US20180163207A1/en not_active Abandoned
-
2020
- 2020-11-09 US US17/092,390 patent/US20210139909A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Vazquez et al. | Clinical efficacy and safety of a novel antifungal, fosmanogepix, in patients with candidemia caused by Candida auris: results from a phase 2 trial | |
| Walsh et al. | Genome-wide association studies of cardiovascular disease | |
| Haas et al. | Associations between CYP2B6 polymorphisms and pharmacokinetics after a single dose of nevirapine or efavirenz in African Americans | |
| RU2009105494A (ru) | Sdf-1-связывающие нуклеиновые кислоты | |
| Janicki et al. | Genome-wide association study using pooled DNA to identify candidate markers mediating susceptibility to postoperative nausea and vomiting | |
| US9206429B2 (en) | Aptamers that bind to IL-6 and their use in treating or diagnosing IL-6 mediated conditions | |
| Cianci et al. | Antiviral activity and molecular mechanism of an orally active respiratory syncytial virus fusion inhibitor | |
| JP2013524792A5 (enExample) | ||
| Dickinson et al. | Comprehensive pharmacokinetic, pharmacodynamic and pharmacogenetic evaluation of once-daily efavirenz 400 and 600 mg in treatment-naive HIV-infected patients at 96 weeks: results of the ENCORE1 study | |
| EA020795B1 (ru) | Генетические маркеры, ассоциированные с ответом на интерферон-альфа | |
| Desai et al. | Efficacy of cochleated amphotericin B in mouse and human mucocutaneous candidiasis | |
| JP2014533098A5 (enExample) | ||
| RU2008136907A (ru) | Нуклеиновые кислоты, связывающиеся с мср-1 | |
| Tang et al. | Role of gene polymorphisms/haplotypes and serum levels of interleukin-17A in susceptibility to viral myocarditis | |
| JP2015501652A (ja) | Ｇａｂｒ−ａ２診断 | |
| JP2009545526A5 (enExample) | ||
| Tepper et al. | FIT-PNAs as RNA-sensing probes for drug-resistant Plasmodium falciparum | |
| EP4172337A1 (en) | Aptamers for personal health care applications | |
| JP2013511259A (ja) | リバビリン誘発性貧血と関連しているマーカー | |
| US20210292762A1 (en) | Icam-1 aptamers, diagnostic and therapeutic uses thereof | |
| JP2008501632A5 (enExample) | ||
| BRPI0807251A2 (pt) | "método de tratamento de uma condição inflamatória em um indivíduo com necessidade do mesmo, método de seleção de um indivíduo para o tratamento ou não de uma condição inflamátoria com um agente anti-inflamatório ou um agente anticoagulante, método de seleção de um grupo de indivíduos para determinar a eficácia de uma droga candidata conhecida ou sespeita de ser útil para o tratamento de uma condição inflamatória, método para aumentar a probabilidade da eficácia de um tratamento com proteína c ou um tratamento com um compsoto similar à proteína c, método para identificar um indivíduo que tem um ou mais genótipo(s) de evento adverso grave, de resposta melhorada, de risco ou de evento adverso grave reduzido, uso de um agente anti-inflamatório ou um agente anticoagulante na manufatura de um medicamento para tratamento de uma condição inflamatória em um subconjunto de indivíduos, pacote comercial, dois ou mais oligonucleotídeos ou ácidos nucléicos de peptídeos de aproximadamente 10 a aproximadamente 400 nucleotídeos, disposição de oligonucleotídeos ou ácidos nucléicos de peptídeos unidos a um suporte sólido e composição" | |
| JP7018544B2 (ja) | 心房細動の処置のためのブシンドロールを伴う方法および組成物 | |
| US10155995B2 (en) | Mutations in PDGFRB and NOTCH3 as causes of autosomal dominant infantile myofibromatosis | |
| CN101892297B (zh) | 高血压易感基因单核苷酸多态性位点的检测方法及其试剂盒 |